Skip to main content
Caplight Logo









Yaso Therapeutics, Inc.

Yaso Therapeutics, Inc.

Private
Frisco, TexasHealthcare & Life Scienceshttps://www.yasotherapeutics.com/

Last Round

Grant

Sep 11, 2025

Total Funding Raised

$3.18M

Company Overview

Yaso Therapeutics, Inc. is a pharmaceutical company that develops non-hormonal contraceptive and antiviral drug products for sexual health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

women's healthbacterial vaginosisbiotechnologybiofilmtopical therapeuticclinical trialsdrug developmentnon-antibioticfemtechmicrobicidepharmaceutical R&Dcontraceptiveclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yaso Therapeutics, Inc. Comparables

Compare Yaso Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Yaso Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gedea Biotech
86%
Osel Inc.
81%
Daré Bioscience Inc
71%

Yaso Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 11, 2025
AcceleratorApr 1, 2023
GrantSep 1, 2018
GrantMay 1, 2006

Key People

Founding team and executive leadership

Barbara North

Co-Founder, Chief Medical Officer

Founding Team

Yaso Therapeutics, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2023

    Springboard Enterprises led the accelerator round.

  • Sep 1, 2018

    Secured $1.5M grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Yaso Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Yaso Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Yaso Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFrisco, Texas
Employee Range7
Year Founded2004
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?